Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(589/week)
Manufacturing
(402/week)
Energy
(331/week)
Technology
(413/week)
Utilities
(228/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
ArcherDX Inc.
Jun 22, 2020
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
Jun 18, 2020
ArcherDX Enters Collaboration with Bristol Myers Squibb to Apply Personalized Cancer Monitoring (PCM(TM)) to Clinical Research
May 26, 2020
ArcherDX Announces Strategic Collaboration with AstraZeneca to Develop Personalized Cancer Monitoring (PCM) Assays for Minimal Residual Disease (MRD)
May 19, 2020
ArcherDX Receives Breakthrough Device Designation to Detect NTRK Gene Fusions
May 07, 2020
ArcherDX Appoints Jason Ryan to Board of Directors
Apr 28, 2020
ArcherDX and UCL Present New Minimal Residual Disease Surveillance Data from their Collaboration at 2020 AACR Virtual Annual Meeting
Mar 25, 2020
ArcherDX Receives Approval for Archer®MET Companion Diagnostic for TEPMETKO® (Tepotinib) in Advanced Non-Small Cell Lung Cancer in Japan
Jan 14, 2020
ArcherDX Personalized Cancer Monitoring (PCM) Technology Designated by FDA as Breakthrough Device
Jan 10, 2020
ArcherDX and Illumina Partner for Future to Co-Market Portfolio of Planned In-Vitro Diagnostic (IVD) Tests
Jan 07, 2020
ArcherDX Appoints Mark Massaro Chief Financial Officer
Dec 17, 2019
ArcherDX Announces Close of $55 Million Series C Financing
Jul 08, 2019
ArcherDX and Ayala Pharmaceuticals Announce Strategic Companion Diagnostic Collaboration
May 29, 2019
ArcherDX Announces the Appointment of Steven J. Kafka, Ph.D. as Executive Chairman of the Board of Directors
Mar 28, 2019
ArcherDX announces collaboration with University College London to Investigate the Novel Use of Cell-Free Circulating Tumor DNA to Detect Disease Recurrence in Lung Cancer Patients
Feb 12, 2019
ArcherDX Announces Broad-Based Strategic Collaboration with Genosity
Jan 08, 2019
ArcherDX's Companion Diagnostic Assay for both Liquid Biopsy and Tissue Specimens Granted Breakthrough Device Designation by U.S. Food and Drug Administration
Sep 05, 2018
ArcherDX, Inc. Names Former Foundation Medicine Executive Steven Kafka, Ph.D. to its Board of Directors
Aug 28, 2018
ArcherDX, Inc. Appoints Marvin H. Caruthers, Ph.D., to its Board of Directors
Mar 20, 2018
ArcherDX Closes $35 Million Series A Financing
Latest News
May 11, 2024
Sky Harbour to Report 2024 Q1 Results and Host Webcast Investor Call Tuesday, May 14, 2024
May 11, 2024
SpinLaunch Board Announces Leadership Transition
May 11, 2024
Altisource Asset Management Corporation Posts Progress Reports on Project Alpha, Phase II, Through April 2024
May 11, 2024
Albany International Declares Dividend
May 11, 2024
GE Vernova Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
May 11, 2024
Westlake Corporation Declares Quarterly Dividend
May 11, 2024
JBT Corporation Declares Quarterly Dividend
May 11, 2024
Ingersoll Rand Successfully Completes $3,300 Million Senior Unsecured Bond Offering and New $2,600 Million...
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events